TradeStation

Get Cash Back and $0 Commissions
+ The Power of TradeStation

Today's Research Reports on Stocks to Watch: Amgen and United States Steel Corporation


[End Subhead]
[Start Distributor]
Accesswire 27-Jul-2017 8:00 AM
[End Distributor]
NEW YORK, NY / ACCESSWIRE / July 27, 2017 /Amgen shares fell into the red on Wednesday despite beating in both revenue and earnings in its second quarter report. Traders were disappointed over analysts concerns about the company's future. Shares of United States Steel Corporation soared higher after a stellar second quarter report.
RDI Initiates Coverage on:
Amgen Inc. https://ub.rdinvesting.com/news/?ticker=AMGN
United States Steel Corporation https://ub.rdinvesting.com/news/?ticker=X
Amgen Inc. shares closed down 2.76% on over 5 million shares traded yesterday. Despite the company reporting a solid quarterly earnings report, traders were discouraged by some negative remarks from analysts. The company posted revenue of $5.8 billion, beating the $5.67 billion that was expected. Adjusted earnings at $3.27 were also above the $3.11 that the Street expected. Concerns about the company's future is what has some analysts feeling pessimistic, plus the fact that Amgen lowered its 2017 revenue forecast to $22.5 billion to $23 billion from $22.3 billion to $23.1 billion. CEO Robert Bradway commented, "Our second quarter financial performance was enabled by strong volume-driven growth for our newer products including Prolia, Kyprolis and Repatha, as well as our other more recently launched drugs."
Analyst Ronny Gal of Bernstein commented that the company's Enbrel product "will burn off throughout the next quarter." Christopher Raymond of Raymond James said the company's aging legacy product franchise, which makes up about two-thirds of total product revenue, is going to continue to face challenges. Geoffrey Porges of Leerink commented, "The company requires new opportunities to offset the further decline of legacy products, and their late-stage pipeline looks embarrassingly bare." The stock has seen gains of 20% this year so far.
Access RDI's Amgen Inc. Research Report at: https://ub.rdinvesting.com/news/?ticker=AMGN
United States Steel Corporation shares closed up 7.33% yesterday on trading volume more than double compared to usual. The company reported its second quarter 2017 financial results and beat in both earnings and revenues. The steel giant reported earnings of $1.07 per share, barring one-time items, which came in way ahead of the 40 cents analysts had expected. Revenue at $3,144 million was also way ahead of the $2,975 million the Street expected. Shares of the stock soared 11% in after-hours trading shortly after the release of the report on Tuesday afternoon.
Access RDI's United States Steel Corporation Research Report at: https://ub.rdinvesting.com/news/?ticker=X
Our Actionable Research on Amgen Inc. (NASDAQ: AMGN) and United States Steel Corporation (NYSE: X) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA charter holder. RDInvesting.com is neither a registered broker dealer or a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
contact@rdinvesting.com
CFA and Chartered Financial Analyst are registered trademarks owned by CFA Institute
SOURCE: RDInvesting.com